Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Nearly 21 million Americans could lose coverage. Meanwhile, the GOP won’t offer a health care replacement until after 2020.
Cancer organizations and the Food and Drug Administration want to broaden eligibility criteria for cancer clinical trials.
Study suggests current lung cancer screening guidelines may be inadequate for HIV-positive people.
Clinical trials often exclude key patient populations, including children and people living with HIV or hepatitis B or C.
People with HIV who have higher viral load and worse immune function appear to be at higher risk for hepatocellular carcinoma.
HIV-positive women had shorter overall survival than HIV-negative women with breast cancer in a study in Botswana.
Cannabis as medicine is back
Treatment with checkpoint inhibitors appears safe and effective for HIV-positive people.
The patient advocacy coalition I Am Essential sent a letter to the HHS spelling out why the plan is dangerous.
HIV, anti-vaxxers, dengue fever and weak primary health care make the World Health Organization’s list of priorities.
A look at the 2019 State of the Union address
More newly diagnosed cancer patients should get tested, says a new study.
Four out of 10 FDA workers are sidelined.
One hundred twenty volunteers to enroll in Seattle-area study of cancer-related gene mutations
Ten HIV-positive cancer patients to receive donated cord blood with rare resistance gene.
Cancer today feels like AIDS in the mid-1990s.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.